Wipfli Financial Advisors LLC Takes $90,000 Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Wipfli Financial Advisors LLC purchased a new stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Rating) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 6,883 shares of the real estate investment trust’s stock, valued at approximately $90,000.

Several other large investors have also modified their holdings of SBRA. Point72 Hong Kong Ltd acquired a new stake in shares of Sabra Health Care REIT in the second quarter valued at approximately $31,000. JFS Wealth Advisors LLC acquired a new stake in Sabra Health Care REIT during the second quarter worth approximately $32,000. Lazard Asset Management LLC acquired a new stake in Sabra Health Care REIT during the second quarter worth approximately $38,000. Lindbrook Capital LLC boosted its position in Sabra Health Care REIT by 60.8% during the second quarter. Lindbrook Capital LLC now owns 2,929 shares of the real estate investment trust’s stock worth $41,000 after acquiring an additional 1,107 shares during the last quarter. Finally, Worth Asset Management LLC acquired a new stake in Sabra Health Care REIT during the first quarter worth approximately $44,000. 87.20% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on SBRA. StockNews.com began coverage on shares of Sabra Health Care REIT in a research report on Wednesday, October 12th. They set a “hold” rating on the stock. Bank of America lowered shares of Sabra Health Care REIT from a “neutral” rating to an “underperform” rating and decreased their target price for the stock from $15.00 to $13.00 in a research report on Monday, November 14th. JMP Securities lowered shares of Sabra Health Care REIT from an “outperform” rating to a “market perform” rating in a report on Tuesday, December 13th. Finally, Robert W. Baird lowered shares of Sabra Health Care REIT from an “outperform” rating to a “neutral” rating and set a $13.00 price target on the stock. in a report on Monday, October 10th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $15.00.

Sabra Health Care REIT Stock Performance

Shares of SBRA stock opened at $13.08 on Thursday. The company’s fifty day simple moving average is $12.66 and its 200-day simple moving average is $13.73. Sabra Health Care REIT, Inc. has a 52 week low of $11.44 and a 52 week high of $16.60. The company has a current ratio of 2.90, a quick ratio of 2.90 and a debt-to-equity ratio of 0.76. The company has a market cap of $3.02 billion, a PE ratio of -163.50 and a beta of 1.26.

Sabra Health Care REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, November 30th. Investors of record on Thursday, November 17th were paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 9.17%. The ex-dividend date was Wednesday, November 16th. Sabra Health Care REIT’s dividend payout ratio (DPR) is -1,500.00%.

Sabra Health Care REIT Profile

(Get Rating)

As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing – Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture.